Microbiome in Obsessive-compulsive Disorder
MIO
Longitudinal Study of Gut Microbiome in Obsessive-Compulsive Disorder
1 other identifier
observational
64
1 country
1
Brief Summary
Background: Humans live in symbiosis with microbes and their implication for health and disease is evident. The importance of microbiome-gut-brain axis in psychiatric disorders is an area of increasing research interest. OCD is a promising target for microbiome research as Pediatric Acute-onset Neuropsychiatric Syndrome (PANS)/ Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) are reactions to infectious agents precipitating acute onset of severe OCD symptoms. Furthermore, preliminary evidence has associated probiotic treatment with alleviation of OCD symptoms. We propose the first clinical study on the microbiome and its effects on OCD patients. Aim: To analyze the gut microbiota in patients with OCD compared with healthy matched controls and assess changes in microbial composition following treatment. Outcome measures: Differences in alpha diversity, beta diversity, and taxa abundance of bacterial groups (at the phylum, class, order, family, genus and species levels) and severity of OCD symptoms. Moreover, functional profiling will be conducted. Methods: Our aim is to enroll 32 OCD patients and 32 matched controls. Shotgun metagenomic sequencing will be used. Sequenced data will be processed followed by non-parametric statistical testing. Significance: gut microbiome in patients with OCD beofre and after ERP treatment has never been done before. The microbial composition may impact on OCD symptoms, severity, and chronicity and could inform future therapeutic possibilities.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2018
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 16, 2018
CompletedFirst Posted
Study publicly available on registry
August 20, 2018
CompletedStudy Start
First participant enrolled
December 5, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 4, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 4, 2022
CompletedSeptember 21, 2022
September 1, 2022
3.8 years
August 16, 2018
September 19, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Alpha diversity
expressed as number of observed species and Chao-1 estimator
2018-09-01
Secondary Outcomes (3)
Beta diversity
2018-09-01
Taxonomic and functional differences between cases and controls
2018-09-01
Change in microtioba diversity before and after ERP treatment
2018-09-01
Study Arms (2)
Healthy controls
Matched Controls without treatment
OCD
Exposure and response inhibition
Interventions
Cognitive behavioural therapy designed for treatment of Obsessive-compulsive disorder
Eligibility Criteria
Recruitment of participants from Karolinska Hospital in Solna and Huddinge. Healthy Controls are recruited from Sweden from advertisements.
You may qualify if:
- DSM-5 diagnosis of OCD. Age matched controls will be recruited who have no personal or family history of OCD.
You may not qualify if:
- history of GI tract surgery (other than appendectomy or cholecystectomy); history of inflammatory bowel disease, irritable bowel syndrome, celiac disease, or any other diagnosis that could explain chronic or recurring bowel symptoms, antibiotic use in the past 3 months; pro-biotic use in the past 4 weeks; pregnancy. Intellectual disability, autism spectrum disorder and psychotic disorders.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
M46: Karolinska Universitetssjukhuset, Psykiatri Sydväst
Stockholm, Huddinge, 141 86, Sweden
Biospecimen
Stool samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Christian Rück, MD
Karolinska Institutet
- PRINCIPAL INVESTIGATOR
Diana Radu Djurfeldt, MD
Karolinska Institutet
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 4 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Rucklab, affiliate professor
Study Record Dates
First Submitted
August 16, 2018
First Posted
August 20, 2018
Study Start
December 5, 2018
Primary Completion
September 4, 2022
Study Completion
September 4, 2022
Last Updated
September 21, 2022
Record last verified: 2022-09